Study suggests, aggressive yet safe treatment for patients with intrahepatic cancer and at high risk for liver damage

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

IMPORTANCE
Patients with preexisting liver dysfunction could benefit the most from personalized therapy for liver tumors to balance maximal tumor control and minimal risk of liver failure. We designed an individualized adaptive trial testing the hypothesis that adapting treatment based on change i...